Autism Spectrum Disorder Clinical Trials in Phoenix, Arizona

8 studies are recruiting for autism spectrum disorder in Phoenix, Arizona right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

   This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophrenia, bipolar disorder or autism spectrum disorder.

   Stage

   Phase 3

   Ages

   5 to 17

   Site

   Southwest Autism Research and Resource Center, Phoenix, Arizona

   Locations

   64 in total

   Run by

   Intra-Cellular Therapies, Inc.

   See if you can join NCT06229210 on ClinicalTrials.gov

2. Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism

   The primary objective of this study is to evaluate the cognitive and behavioral effects of liquid leucovorin calcium on young children with autism spectrum disorder (ASD) and determine whether it improves social communication as well as the core and associated symptoms of ASD. The investigators wil…

   Stage

   Phase 2

   Ages

   2 to 5

   Site

   Southwestern Research & Resource Center, Phoenix, Arizona

   Locations

   2 in total

   Run by

   Southwest Autism Research & Resource Center

   See if you can join NCT04060030 on ClinicalTrials.gov

3. International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder

   To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication

   Stage

   Not phased

   Ages

   12 to 65

   Site

   SARRC, Phoenix, Arizona

   Locations

   21 in total

   Run by

   Stalicla SA

   See if you can join NCT05590715 on ClinicalTrials.gov

4. Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

   The study involves up to 5 visits for a fasting blood draw, behavioral assessments, and/or questionnaires. Other samples may be collected when appropriate. This study is currently recruiting. There is no cost for visits or study-related exams.

   Stage

   Not phased

   Ages

   Up to 18

   Site

   Southwestern Research and Resource Center, Phoenix, Arizona

   Locations

   2 in total

   Run by

   Southwest Autism Research & Resource Center

   See if you can join NCT04322734 on ClinicalTrials.gov

5. Patterns of Neurodevelopmental Disorders

   The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.

   Stage

   Not phased

   Ages

   Any age

   Site

   Rossignol Medical Center, Phoenix, Arizona

   Run by

   Richard Frye

   See if you can join NCT06213090 on ClinicalTrials.gov

6. TB006 for Autism Spectrum Disorder

   Multisite 14-week prospective double-blind placebo controlled parallel-group randomized clinical trial with 14-week open-label extension at the end of double-blind treatment phase for placebo subjects. Eligible subjects will be randomized within each site in 2:1 ratio to receive either TB006 or pla…

   Stage

   Phase 2

   Ages

   18 to 35

   Site

   Rossignol Medical Center, Phoenix, Arizona

   Locations

   2 in total

   Run by

   Rossignol Medical Center

   See if you can join NCT06500637 on ClinicalTrials.gov

7. Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults

   The goal of this clinical trial is to learn if drug ABC works to treat severe asthma in adults. It will also learn about the safety of drug ABC. The main questions it aims to answer are: Will a marijuana-based drug help anxiety in autistic adults? Anxiety can make socializing and working more diffi…

   Stage

   Phase 2

   Ages

   18 to 45

   Site

   Southwest Autism Research and Resource Center, Phoenix, Arizona

   Run by

   Southwest Autism Research & Resource Center

   See if you can join NCT06526208 on ClinicalTrials.gov

8. Telehealth Mindfulness-based Intervention for Adolescents With Autism Spectrum Disorder and Their Caregivers

   The goal of this clinical trial is to learn whether a mindfulness-based intervention can reduce depression and anxiety in autistic adolescents. The main question this trial aims to answer is: Do adolescents who complete MINDful TIME show reductions in depression and anxiety compared to an active co…

   Stage

   Not phased

   Ages

   13 to 18

   Site

   Southwest Autism Research & Resource Center, Phoenix, Arizona

   Run by

   Nicole Matthews, Ph.D.

   See if you can join NCT07501286 on ClinicalTrials.gov